Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.41 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21296942 | 0.87 | ALDH1A1 (0.43) | BCL2 | |
| SCHEMBL29799129 | 0.87 | ALDH1A1 (0.43) | BCL2 | |
| SCHEMBL21296966 | 0.84 | ALPL (0.43) | — | |
| SCHEMBL21296854 | 0.84 | HAO1 (0.44) | — | |
| SCHEMBL21296929 | 0.84 | PIN1 (0.49) | — | |
| SCHEMBL29799054 | 0.82 | HAO1 (0.47) | — | |
| SCHEMBL21312597 | 0.82 | HAO1 (0.47) | — | |
| SCHEMBL21312624 | 0.82 | HAO1 (0.47) | — | |
| SCHEMBL24154727 | 0.82 | RXRA (0.52) | — | |
| SCHEMBL21296954 | 0.81 | PRKAG1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230143491-A1 | TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | PHOENIX TISSUE REPAIR, INC. | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143491-A1 | TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | XDH, DUOX1, PNPO | BCL2 4223/4885PTGS2 1093/4885FGFR1 657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.